Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2016 Apr;101(4):1318-43. doi: 10.1210/jc.2016-1271.

Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.

Author information

1
Departments of Obstetrics and Gynecology (N.S.) and Medicine (M.M.), University of Colorado School of Medicine, Aurora, Colorado 80045; Department of Medicine (G.D.B.), Cedars-Sinai Medical Center, Los Angeles, California 90048; Program Leadership (C.L.B.), Biogen, Cambridge, Massachusetts 02142; Department of Medicine (K.A.M.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Department of Obstetrics and Gynecology (J.V.P.), Midlife Health, University of Virginia, Charlottesville, Virginia 22908.

Abstract

This Scientific Statement finds that there is no rationale for routine prescribing of unregulated, untested, and potentially harmful custom compounded bioidentical hormone therapies.

PMID:
27032319
DOI:
10.1210/jc.2016-1271
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center